aMERICA’s Leading Healthcare Pricing, Access and Evidence Congress

Blythe Adamson, PhD, MPH, is a health economist and epidemiologist who assesses the value of new technologies, medicines, and policies. She is the Founder and CEO of Infectious Economics, an advisory firm she launched in 2017 to serve government agencies, life sciences and technology companies. She ...

Michael J. Baldzicki Vice President, BioPharma & AccessWalgreens Enterprise Specialty Pharmacy Michael J. Baldzicki is Vice President, BioPharma & Access for Walgreens Enterprise Specialty Pharmacy, where he leads strategies focused on expanding pharmaceutical manufacturer...

Niall Brennan is Chief Data and Analytics Officer at Horizon Blue Cross and Blue Shield.  Previously Niall was the Senior Advisor for Data Strategy to the CDC Director where he provided guidance to the CDC Director on the multi-billion dollar CDC Data Modernization Initiative (DMI), as well as...

Christopher A. Hatwig, MS, RPh, FASHP, is President of Apexus and a nationally recognized healthcare executive and expert in the 340B Drug Pricing Program, specialty pharmacy, and medication access. He leads Apexus in its role as HRSA’s contracted 340B Prime Vendor and in developing innovative...

Divya Iyer is the Senior Vice President, Head of Revenue, Pharma Direct at GoodRx, where she oversees the teams responsible for building, scaling, and sustaining pharmaceutical manufacturer partnerships that help patients access their medications more affordably and with less friction. Prior to...

Ankur Jain Esq is the founder of Artha Consulting Lab, an independent advisory practice focused on how healthcare organizations actually adopt artificial intelligence. He is the author of the AI Readiness Continuum (ARC), a vendor-neutral framework for healthcare AI adoption, and the host of The...

Chris is the Senior Vice President and Head of US Market Access at AstraZeneca. In this role, he oversees efforts to communicate the value proposition of AstraZeneca's product portfolio to payers, the US government, and other key access stakeholders. Additionally, he leads initiatives to...

Andrew Spiegel has more than two decades of experience in the patient advocacy arena. Currently, Spiegel is in his 10th year as CEO of the Global Colon Cancer Association, an umbrella organization of all colorectal/bowel cancer organizations worldwide. In addition, Spiegel is in his 3rd year as...

Dr. Gillian Stynes is an accomplished pharmaceutical executive with extensive experience in developing and executing successful global pricing & reimbursement strategies. She possesses a deep understanding of HTA, pricing dynamics, payer policy and market trends, allowing her to navigate...

Sean D. Sullivan, BScPharm, MSc, PhD, is Professor, School of Pharmacy and Visiting Professor (2022-2027), London School of Economics and Political Science. He holds a joint appointment as Professor of Health Services and Population Health, School of Public Health. Dr. Sullivan was Dean of the...

Reg is currently the Head of Global Market Access at Bayer which includes team members responsible for Market Access, Pricing & Value Optimization and Health Economics & Outcomes Research. He is a biopharma leader with over 25 years experience in Pharma and Biotech in the US, Australia and...

Alexandra Williams is a recognized healthcare strategy leader with over 15 years of 340B Drug Pricing Program expertise across provider, consulting, and pharmaceutical sectors. Alexandra serves as Director, Strategy & Innovation, as part of AbbVie’s 340B Center of Excellence,  leading the 340B...